Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
---|
06/22/1994 | CA2112027A1 Prostaglandin combinations in glaucoma therapy |
06/21/1994 | US5322850 Antiallergic piperidine derivatives of benzimidazole |
06/18/1994 | CA2111644A1 Use of thrombin inhibitors for the inhibition of ocular fibrin formation |
06/17/1994 | CA2111362A1 Imidazopyridines |
06/15/1994 | CA2111302A1 3-(6-quinolylmethyl)-4h-imidazol-4-one derivatives, their preparation and their application in therapy |
06/14/1994 | US5321039 Method of inducing a histamine agonist action on H2 receptors |
06/14/1994 | US5321017 Composition comprising fluriprofen and effectively non-antibacterial tetracycline to reduce bone loss |
06/14/1994 | US5320841 Vision disorders, ophthalmology |
06/09/1994 | WO1994012488A1 Nitroxy compounds with pharmaceutical properties |
06/09/1994 | WO1994012466A1 Fatty acid derivatives and pharmaceutical compositions containing them |
06/09/1994 | WO1993012093A1 Imidazolyl-alkyl-piperazine and -diazepine derivatives as histamine h3 agonists/antagonists |
06/08/1994 | EP0517789B1 Inhibitor of proliferation of endothelial cells |
06/01/1994 | EP0577646A4 Sustained release drug delivery devices |
05/26/1994 | WO1994011342A1 Substituted arylalkynyl- and heteroarylalkynyl-n-hydroxyurea inhibitors of leukotriene biosynthesis |
05/26/1994 | CA2136077A1 Substituted arylalkynyl- and heteroarylalkynyl-n-hydroxyurea inhibitors of leukotriene biosynthesis |
05/25/1994 | EP0597968A1 New leukotriene-b 4? antagonists, methods of preparing them and their use as drugs |
05/25/1994 | EP0358660B1 Synthetic inhibitors of mammalian collagenase |
05/24/1994 | US5314880 Benzimidazole derivatives |
05/24/1994 | US5314697 Stable extended release oral dosage composition comprising loratadine and pseudoephedrine |
05/17/1994 | US5312832 Ocular hypotensive 2-decarboxyl-2-acylthioalkyl prostaglandin derivatives |
05/17/1994 | CA1329620C Ethynylphenyl-containing retinoic acid derivatives |
05/11/1994 | WO1994010314A1 Allergenic proteins and peptides from johnson grass pollen |
05/11/1994 | WO1994010193A1 Novel mercaptoacetylamide bicyclic lactam derivatives useful as inhibitors of enkephalinase and ace |
05/11/1994 | WO1994010148A1 Aryl and heteroarylmethoxyphenyl inhibitors of leukotriene biosynthesis |
05/11/1994 | WO1994009815A1 USES OF TGF-β RECEPTOR FRAGMENT AS A THERAPEUTIC AGENT |
05/11/1994 | WO1994009794A1 Ophthalmic solution and method of use |
05/11/1994 | WO1994009761A1 Stable extended release oral dosage composition |
05/11/1994 | CA2148108A1 Ophthalmic solution and method of use |
05/11/1994 | CA2136076A1 Aryl and heteroarylmethoxyphenyl inhibitors of leukotriene biosynthesis |
05/10/1994 | US5310743 1-acylpiperidine compounds |
05/05/1994 | DE4335366A1 Verfahren zur Herstellung eines kristallinen Typ A Botulinum Toxins als therapeutische Arznei A process for preparing a crystalline botulinum toxin type A as a therapeutic drug |
05/04/1994 | EP0595769A1 Method of disinfecting a contact lens and preserving a contact lens care solution |
05/04/1994 | EP0595610A1 Benzo-fused lactams |
05/04/1994 | EP0410006B1 Eye drops for healing wound of corneal epithelium |
05/04/1994 | CN1086214A Di-and triazinediones |
05/04/1994 | CN1086132A Pharmaceutical composition for topical application to the eye for treating increased intraocular pressure |
05/03/1994 | US5308863 Substituted aromatic sulfonamides as antiglaucoma agents |
05/03/1994 | US5308849 Ajmaline |
05/03/1994 | US5308846 Vision defects, hypotensive agents |
05/03/1994 | US5308842 Ocular hypotensive agents; glaucoma |
05/03/1994 | US5308624 Ophthalmic product |
04/29/1994 | CA2107443A1 Benzo-fused lactams |
04/28/1994 | WO1994008990A1 N-arylheteroarylalkyl 1-phenyl-imidazol-2-one compounds for treatment of circulatory disorders |
04/28/1994 | WO1994008602A1 Composition for irrigating intraocular tissues and maintaining mydriasis during intraocular surgery |
04/28/1994 | WO1994008588A1 Pharmaceutical compositions containing 3-beta-hydroxylated natural steroid derivatives, and use thereof |
04/28/1994 | WO1994008587A1 Novel 7-(5-substituted cyclopentyl) and (5-substituted cyclopentenyl) heptyl alcohols, heptylamines and heptanoic acid amines, and method of lowering intraocular pressure in the eye of a mammal by administration of these novel compounds |
04/28/1994 | WO1994008585A1 Combinations of prostaglandins and clonidine derivatives for the treatment of glaucoma |
04/28/1994 | CA2147352A1 Pharmaceutical compositions containing 3-beta-hydroxylated natural steroid derivatives and use thereof |
04/28/1994 | CA2143193A1 N-arylheteroarylalkyl 1-phenyl-imidazol-2-one compounds for treatment of circulatory disorders |
04/28/1994 | CA2126093A1 Composition for irrigating intraocular tissues and maintaining mydriasis during intraocular surgery |
04/27/1994 | EP0593520A1 Ocular compositions containing steroids and their use in treating glaucoma |
04/27/1994 | CN1085899A 7-(2-aminoethyl)-benzothiazolones |
04/27/1994 | CN1085897A Angiotension II antagonists |
04/27/1994 | CA2109019A1 Method of disinfecting a contact lens and preserving a contact lens care solution |
04/26/1994 | US5306731 Method and products for treating the eye |
04/19/1994 | US5304569 Compositions and their use in lowering intraocular pressure |
04/19/1994 | US5304559 Compositions containing a 4-quinolone derivative complexed with a divalent metal ion |
04/19/1994 | US5304557 Substituted oxoophthalazinyl acetic acids and analogs thereof |
04/19/1994 | US5304552 Renin inhibitors |
04/19/1994 | CA1328665C Lacrimal secretion stimulant (lss) |
04/19/1994 | CA1328614C Preservative system for ophthalmics formulations |
04/19/1994 | CA1328608C Glaucoma treatment |
04/19/1994 | CA1328605C Medicinal composition useful for the treatment of dermatological diseases |
04/14/1994 | WO1994007867A1 Substituted pyrimidines for control of diabetic complications |
04/13/1994 | EP0591891A2 Benzimidazole derivatives as Angiotensin II antagonists |
04/13/1994 | CN1085082A Vitamin E drop |
04/07/1994 | CA2107604A1 Benzimidazole, pharmaceutical compositions containing these compounds and processes for preparing them |
04/06/1994 | EP0590972A1 Treatment of ocular hypertension with a synergistic combination |
04/06/1994 | EP0590789A1 Excitatory amino acid receptor antagonists |
04/06/1994 | EP0590786A1 Use of certain anionic surfactants to enhance antimicrobial effectiveness of opthalmic compositions |
04/06/1994 | EP0590549A1 Process for preparing thienothiopyran derivative |
04/06/1994 | EP0590152A1 Peptides with tachykinin antagonist activity |
04/05/1994 | US5300674 Antiarthritic, antitumor agents; for osteoporosis, corneal ulceration |
04/05/1994 | US5300504 Increasing renal fluid flow |
04/05/1994 | CA1328263C Substituted thieno[2,3-b]furan-2-sulfonamides as antiglaucoma agents |
04/05/1994 | CA1328262C Substituted aromatic sulfonamides as antiglaucoma agents |
04/05/1994 | CA1328261C Thiophene sulfonamide antiglaucoma agents |
03/31/1994 | WO1994006433A1 Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents |
03/31/1994 | WO1994006411A1 Topical carbonic anhydrase inhibitor composition |
03/31/1994 | CA2141879A1 Topical carbonic anhydrase inhibitor composition |
03/30/1994 | EP0589703A1 Proline derivative of rapamycin, production and application thereof |
03/30/1994 | EP0589201A1 Di- and triazindeones |
03/29/1994 | US5298505 Ethynyl alanine amino diol compounds having a piperazinyl-terminated group or a piperazinyl-alkylamino-terminated group for treatment of hypertension |
03/29/1994 | US5298489 DNA sequences recombinant DNA molecules and processes for producing lipocortins III, IV, V and VI |
03/29/1994 | CA1328106C Anticholinergic compounds, pharmaceutical compositions and method of treatment |
03/29/1994 | CA1328075C Ocular hypotensive agents |
03/25/1994 | CA2106034A1 21-norrapamycin |
03/23/1994 | EP0587698A1 Substituted 1-(2h)-isoquinolinones bearing acidic functional groups as angiotensin ii antagonists |
03/23/1994 | CN1084079A Ophthalmic compositions |
03/22/1994 | US5296505 Reacting dithianepropenol with ethynyl-beta-ionol in presence of organomagnesium compound, hydrogenating triple bond, reducing diol with low-valency titanium |
03/22/1994 | US5296486 Leukotriene biosynthesis inhibitors |
03/22/1994 | US5296472 Methods for delipidation of skin and cerumen removal |
03/17/1994 | WO1994005674A1 Tricyclic derivatives of the thienodiazocine and thienothiadiazocine classes of compounds |
03/17/1994 | WO1994005631A1 9-chloroprostaglandin esters and amides and their use in the preparation of drugs |
03/17/1994 | WO1994005274A1 Glycation inhibitor |
03/17/1994 | WO1994000095A3 Use of calpain inhibitors in the inhibition and treatment of medical conditions associated with increased calpain activity |
03/17/1994 | WO1993025530A3 Vinyl arenas having retinoid-like activity |
03/17/1994 | CA2141965A1 Tricyclic derivatives of the thienodiazocine and thienothiadiazocine classes of compounds |
03/16/1994 | EP0587264A1 Aqueous pharmaceutical formulations of sodium cromoglycate |
03/16/1994 | EP0586537A1 Substituted n-carboxyalkylpeptidyl derivatives as antidegenerative active agents |